Results 221 to 230 of about 37,561 (261)
Galectin-3-Insights from Inflammatory Bowel Disease and Primary Sclerosing Cholangitis. [PDF]
Grewal T, Tews HC, Buechler C.
europepmc +1 more source
The Significance of Enzymatic Cholestasis in Inflammatory Bowel Disease Patients for the Diagnosis of Primary Sclerosing Cholangitis-A Retrospective Study. [PDF]
Mandea M +6 more
europepmc +1 more source
Apremilast as a novel therapeutic option for psoriasis coexisting primary sclerosing cholangitis and ulcerative colitis: A case report. [PDF]
Gao J +6 more
europepmc +1 more source
Multimodal transcriptomics identifies metallothionein as a novel pathway in primary sclerosing cholangitis. [PDF]
Chung BK +8 more
europepmc +1 more source
Prognosis of pediatric-onset inflammatory bowel disease associated with primary sclerosing cholangitis: A population-based study. [PDF]
Godet ML +10 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Primary sclerosing cholangitis
The Lancet, 2018Primary sclerosing cholangitis is a rare, chronic cholestatic liver disease characterised by intrahepatic or extrahepatic stricturing, or both, with bile duct fibrosis. Inflammation and fibrosis of bile ducts and the liver are followed by impaired bile formation or flow and progressive liver dysfunction.
Dyson JK +4 more
openaire +5 more sources
Primary Sclerosing Cholangitis
Clinics in Liver Disease, 2013Primary sclerosing cholangitis (PSC) is a chronic, progressive, cholestatic liver disease characterized by multifocal strictures of intra and extrahepatic bile ducts. PSC occurs more commonly in men and is often associated with inflammatory bowel disease. At present, there is no effective medical therapy for PSC. Current management of patients with PSC
Gideon M, Hirschfield +3 more
exaly +6 more sources
Primary Sclerosing Cholangitis
New England Journal of Medicine, 1995Y M, Lee, M M, Kaplan
openaire +4 more sources

